Ocular Therapeutix
OCUL
OCUL
135 hedge funds and large institutions have $224M invested in Ocular Therapeutix in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.81% more ownership
Funds ownership: 52.24% → 56.05% (+3.8%)
5% more capital invested
Capital invested by funds: $214M → $224M (+$10.4M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
135
Holding in Top 10
2
Calls
$4.99M
Puts
$1.99M
Top Buyers
| 1 | +$7.02M | |
| 2 | +$4.14M | |
| 3 | +$3.75M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.33M |
| 5 |
Axa
Paris,
France
|
+$2.45M |
Top Sellers
| 1 | -$4.9M | |
| 2 | -$2.29M | |
| 3 | -$1.93M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.68M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.43M |